143K views · 792 reactions | CAR T-cell therapy is a promising treatment for some of the most challenging cases we face in pediatric acute lymphoblastic leukemia (ALL). Lewis Silverman, MD, explains what makes this treatment so significant and what it means for leukemia patients. | Dana-Farber Cancer Institute | Facebook

Dr. Siddhartha Mukherjee’s recent initiative in Bengaluru, Immuneel Therapeutic Ltd, in collaboration with biotech entrepreneur Kiran Mazumdar Shaw, has been rolling out a crucial clinical trial on the treatment of cancer, called the Chimeric Antigen Receptor (CAR) T-cell therapy, already in use in several countries, that will significantly bring down the cost of therapy for patients in India. #cancer #CancerResearch #SiddharthaMukherjee #KiranMazumdarShaw | Indian Express | Facebook